Actively Recruiting
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
Led by Makerere University · Updated on 2022-07-12
2400
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
Sponsors
M
Makerere University
Lead Sponsor
U
University of Minnesota
Collaborating Sponsor
AI-Summary
What this Trial Is About
A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.
CONDITIONS
Official Title
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years
- CD4 count below 200 cells/µL
- Ability and willingness to give informed consent for the enhanced package of care
You will not qualify if you...
- Known viral suppression with viral load under 1000 copies/mL within the past 3 months
- Unable or unlikely to attend regular clinic visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
kisugu health center IV
Kampala, Uganda
Actively Recruiting
Research Team
R
Radha Rajasingham, MD
CONTACT
E
Elizabeth Nalintya, MBChB,MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here